Gujarat Terce Laboratories Limited · BSE:GUJTERC

Gujarat Terce Laboratories — Q3 FY25 Earnings Presentation

7 slides from Gujarat Terce Laboratories's earnings presentation, Feb 4, 2025

  1. Slide 1: BSE filing cover letter for investor presentation

    IL Date: 04-02-2025 To, Scrip Code: 524314 BSE Limited Security ID: GUJTERC Corporate Relation Department Phiroze ISIN: INE499G01013 Jeejeebhoy Towers, Dalai Streets, Mumbai- 400001, Maharashtra, India Dear Sir/Madam, Sub: Investors Presentation for Quarter ended on December 31,2024 Pursuant to Regu

  2. Slide 2: Q3 FY25 Financial Results & Business Update

    GUJARAT TERCE LABORATORIES LABORATORI LIMITED ITED Q3 FY25| | FINANCIAL RESULTS Q3 FY25 RESULTS&& BUSINESS UPDATE

  3. Slide 3: Safe Harbour

    SAFE HARBOUR THIS PRESENTATION CONTAINS CERTAIN FORWARD-LOOKING STATEMENTS CONCERNING OUR OUR FUTURE BUSINESS PROSPECTS AND AND BUSINESS PROFITABILITY, WHICH ARE SUBJECT TO TO SEVERAL RISKS AND UNCERTAINTIES&& THE AND UNCERTAINTIES THE ACTUAL RESULTS COULD MATERIALLY DIFFER FROM THOSE INSUCH IN SUCH

  4. Slide 4: Performance Highlights

    PERFORMANCE HIGHLIGHTS JLR REVENUE EBIDTA NET NET PROFIT PCPM Q3/FY24 Q3/FY25 Q3/FY24 Q3/FY25 Q3/FY24 Q3/FY25 Q3/FY24 Q3/FY25 [1302] [1268.08] 1268.08] (92.69] [92.69] [115.75] [115.75] [67.28] [67.28] [100.8] 100.8] 200) [2.00] [2.73] [2.73] [-3]%% [-3] [25]%% [25] [s0]%% [50] [365)%% [36.5] Degrow

  5. Slide 5: Profit & Loss Summary

    PROFIT&& LOSS SUMMARY JL R (INR Crore) Particulars Q3 FY25 Q3 FY24 Change % 9 M FY25 9 M FY24 Change % 2023-24 Revenue 1268.08 1302.02 (3) % 3787.08 3576.76 5.88 % 4797.47 EBITDA 115.75 92.69 25 % 305.09 50.16 508.23 % 158.7 Cash Profit 110.33 76.39 44 % 269.47 (2.66) 61 PBT 97.77 67.28 45 % 242.20

  6. Slide 6: Management Commentary

    MANAGEMENT COMMENTARY Dear Shareholders, On behalf of the On the entire team at atGujarat Gujarat Terce Laboratories Limited, Limited,II am am pleased to share our financial performance forQ3 Our strategic for Q3 FY25. Our We We remain and operational initiatives and operational excellence continue

  7. Slide 7: About the Company

    ABOUT THECOMPANY THE COMPANY JLR Gujarat Terce has over three decades of ofexperience and experience in manufacturing and marketing branded generics to provide the general public with accessible healthcare. healthcare. COMPASSION&& EXCELLENCE COMPASSION • We 50 Brands (125 products) witha We have a

Gujarat Terce Laboratories — Q3 FY25 Earnings Presentation on 6ix